Gene expression signatures modulated by epidermal growth factor receptor activation and their relationship to cetuximab resistance in head and neck squamous cell carcinoma
<p>Abstract</p> <p>Background</p> <p>Aberrant activation of signaling pathways downstream of epidermal growth factor receptor (EGFR) has been hypothesized to be one of the mechanisms of cetuximab (a monoclonal antibody against EGFR) resistance in head and neck squamous...
Main Authors: | Fertig Elana J, Ren Qing, Cheng Haixia, Hatakeyama Hiromitsu, Dicker Adam P, Rodeck Ulrich, Considine Michael, Ochs Michael F, Chung Christine H |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-05-01
|
Series: | BMC Genomics |
Online Access: | http://www.biomedcentral.com/1471-2164/13/160 |
Similar Items
-
Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
by: Greg Knutzen, et al.
Published: (2015-11-01) -
Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
by: J Greenhalgh, et al.
Published: (2009-10-01) -
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
by: Olivia Leblanc, et al.
Published: (2020-02-01) -
Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma.
by: Hiromitsu Hatakeyama, et al.
Published: (2010-09-01) -
Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck
by: S Griffin, et al.
Published: (2009-06-01)